ZIVO Bioscience Overview
- Year Founded
-
1983
- Status
-
Public
- Employees
-
7
- Stock Symbol
-
ZIVO
- Investments
-
3
- Share Price
-
$4.94
- (As of Friday Closing)
ZIVO Bioscience General Information
Description
Zivo Bioscience Inc operates in one reportable segment microalgae technology. The segment is research and development operating in both the therapeutic and nutritional sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company's applications are ANIMAL APPLICATIONS, HUMAN APPLICATIONS.
Contact Information
Website
www.zivobioscience.comCorporate Office
- 21 East Long Lake Road
- Suite 100
- Bloomfield Hills, MI 48320
- United States
Corporate Office
- 21 East Long Lake Road
- Suite 100
- Bloomfield Hills, MI 48320
- United States
ZIVO Bioscience Stock Performance
As of 20-Nov-2026, ZIVO Bioscience’s stock price is $4.94. Its current market cap is $21.2M with 4.29M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.94 | $5.50 | $1.10 - $12.04 | $21.2M | 4.29M | 1.11K | -$2.18 |
ZIVO Bioscience Financials Summary
As of 30-Sep-2025, ZIVO Bioscience has a trailing 12-month revenue of $209K.
|
In Thousands, USD |
TTM 30-Sep-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 61,803 | 76,464 | 2,201 | 20,767 |
| Revenue | 209 | 157 | 28 | 0 |
| EBITDA | (8,458) | (13,362) | (7,263) | (8,732) |
| Net Income | (8,486) | (13,385) | (7,777) | (8,745) |
| Total Assets | 559 | 1,643 | 556 | 2,123 |
| Total Debt | 820 | 254 | 346 | 445 |
ZIVO Bioscience Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
ZIVO Bioscience Comparisons
Industry
Financing
Details
ZIVO Bioscience Competitors (7)
One of ZIVO Bioscience’s 7 competitors is Bon Opus Biosciences, a Corporation company based in Millburn, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Bon Opus Biosciences | Corporation | Millburn, NJ | ||||
| BPS Bioscience | Corporation | San Diego, CA | ||||
| Cargill | Corporation | Minneapolis, MN | ||||
| BioMar Group | Corporate Backed or Acquired | Aarhus, Denmark | ||||
| Nestlé | Corporation | Vevey, Switzerland |
ZIVO Bioscience Patents
ZIVO Bioscience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260069641-A1 | Gram-negative bacteria for use in the prevention and treatment of disease in poultry | Pending | 14-Jun-2024 | ||
| WO-2025260072-A1 | Gram-negative bacteria for use in the prevention and treatment of disease in poultry | Pending | 14-Jun-2024 | ||
| AU-2022407031-A1 | Brevundimonas sp for use in disease prevention and treatment | Pending | 07-Dec-2021 | ||
| CA-3237976-A1 | Brevundimonas sp for use in disease prevention and treatment | Pending | 07-Dec-2021 | ||
| EP-4422416-A1 | Brevundimonas sp for use in disease prevention and treatment | Pending | 07-Dec-2021 | A61K35/74 |
ZIVO Bioscience Signals
ZIVO Bioscience Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
ZIVO Bioscience Acquisitions (3)
ZIVO Bioscience’s most recent deal was a Merger/Acquisition with Wellness Indicators. The deal was made on 22-Aug-2013.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Wellness Indicators | 22-Aug-2013 | Merger/Acquisition | Monitoring Equipment | ||
| Wellness Indicators (Assets and Intellectual Property) | 19-Aug-2013 | Merger/Acquisition | Asset Management | ||
| Western Glory Hole | 09-Oct-2003 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) |
ZIVO Bioscience ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
ZIVO Bioscience FAQs
-
When was ZIVO Bioscience founded?
ZIVO Bioscience was founded in 1983.
-
Where is ZIVO Bioscience headquartered?
ZIVO Bioscience is headquartered in Bloomfield Hills, MI.
-
What is the size of ZIVO Bioscience?
ZIVO Bioscience has 7 total employees.
-
What industry is ZIVO Bioscience in?
ZIVO Bioscience’s primary industry is Biotechnology.
-
Is ZIVO Bioscience a private or public company?
ZIVO Bioscience is a Public company.
-
What is ZIVO Bioscience’s stock symbol?
The ticker symbol for ZIVO Bioscience is ZIVO.
-
What is the current stock price of ZIVO Bioscience?
As of 20-Nov-2026 the stock price of ZIVO Bioscience is $4.94.
-
What is the current market cap of ZIVO Bioscience?
The current market capitalization of ZIVO Bioscience is $21.2M.
-
What is ZIVO Bioscience’s current revenue?
The trailing twelve month revenue for ZIVO Bioscience is $209K.
-
Who are ZIVO Bioscience’s competitors?
Bon Opus Biosciences, BPS Bioscience, Cargill, BioMar Group, and Nestlé are some of the 7 competitors of ZIVO Bioscience.
-
What is ZIVO Bioscience’s annual earnings per share (EPS)?
ZIVO Bioscience’s EPS for 12 months was -$2.18.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process